| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.09 | 0.04 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.04 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |